RxDoctor Payments Data

Sarah Smoes, PA

Physician Assistant · Cadillac, MINPI 1356437263

Payments from drug & device makers

$2,542in general payments, 2019–2025

Across 136 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$966
  • AbbVie$450
  • Otsuka America Pharmaceutical, Inc.$307
  • Neurocrine Biosciences, Inc.$285
  • Alkermes, Inc.$232
  • E.r. Squibb & Sons, L.L.C.$153
  • plus $149 from 4 others

What the payments were for

  • Food & beverage$2,09682%
  • Education$44618%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,542 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$37,288
Medicare patients
91
Services billed
474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate36$327,376
Abilify MaintenaAripiprazole54$143,064
Invega SustennaPaliperidone Palmitate36$80,644
VraylarCariprazine Hcl40$58,250
FanaptIloperidone12$26,208
Clozapine339$23,738
LybalviOlanzapine/Samidorphan Malate11$16,325
Lurasidone Hcl40$14,870
Paliperidone ErPaliperidone69$8,266
Quetiapine Fumarate231$5,910
Divalproex Sodium ErDivalproex Sodium175$5,447
Varenicline Tartrate15$4,677
Aripiprazole164$4,353
Risperidone278$3,575
Benztropine Mesylate257$3,240

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$74$408,02072 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$307$143,06454 claims
AbbVieVraylar$450$58,25040 claims
Vanda Pharmaceuticals Inc.Fanapt$39$26,20812 claims
Alkermes, Inc.Lybalvi$232$16,32511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Cadillac

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →